KLDO
Kaleido Biosciences, Inc.
Set alert
0.00 USD 0.00 0.00%
0.0001 Day range 0.0001
0.00001 52-week range 0.005
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 4.26K
- Vol
- 1.05K
- Avg vol
- 942
- EPS
- -2.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- -0.06
- Beta
- -0.10
- Short ratio
- 29.34
- Inst. own
- 79.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2022
- 50-d avg
- 1.15
- 200-d avg
- 3.55
- 1y target
- 22.00
Financial health
Altman Z-Score
-15.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.1×
FY 2016 5y median -3.7× FY 2021
P/S 90.6×
FY 2016 5y median 0.0× FY 2021
P/B 9.4×
FY 2016 5y median 7.2× FY 2021
P/FCF -1.3×
FY 2016 5y median -4.6× FY 2021
EV/EBITDA -1.0×
FY 2016 5y median -3.6× FY 2021
EV/Sales 75.4×
FY 2016 5y median 0.0× FY 2021
FCF Yield -78.2%
FY 2016 5y median -21.5% FY 2021
Profitability
Gross Margin -113.6%
FY 2016 5y median 0.0% FY 2021
Operating Margin -7940.9%
FY 2016 5y median 0.0% FY 2021
Net Margin -8178.3%
FY 2016 5y median 0.0% FY 2021
ROE -851.2%
FY 2016 5y median -173.9% FY 2021
ROIC -239.5%
FY 2016 5y median -120.4% FY 2021
ROA -180.1%
FY 2016 5y median -103.3% FY 2021
Growth (YoY)
Revenue 13.2%
FY 2016 FY 2021
Operating Income -11.1%
FY 2016 FY 2021
EPS (diluted) 11.5%
FY 2016 FY 2021
Free Cash Flow -19.3%
FY 2016 FY 2021
Financial Health
Current Ratio 1.4×
FY 2016 5y median 6.7× FY 2021
Quick Ratio 1.4×
FY 2016 5y median 6.7× FY 2021
Debt / Equity 2.0×
FY 2016 5y median 0.4× FY 2021
Net Debt / EBITDA 0.2×
FY 2016 5y median 0.5× FY 2021
Interest Coverage -30.9×
FY 2016 5y median -60.4× FY 2021
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31